Akero Therapeutics, Inc. Total Liabilities
Akero Therapeutics, Inc. had Total Liabilities of $47.94 million as of 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2025-11-07
- 2025-09-30: Liabilities $47.94M.
- 2025-06-30: Liabilities $83.33M.
- 2025-03-31: Liabilities $72.00M.
- 2024-12-31: Liabilities $75.77M.
| Period end | Liabilities |
|---|---|
| 2025-09-30 | $47.94M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $83.33M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $72.00M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $75.77M 10-Q · filed 2025-11-07 |
| 2024-09-30 | $79.22M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $66.98M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $65.99M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $44.97M 10-K · filed 2025-02-28 |
| 2023-09-30 | $52.20M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $47.37M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $42.47M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $30.01M 10-K · filed 2024-02-29 |
| 2022-09-30 | $35.90M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $37.30M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $23.35M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $26.44M 10-K · filed 2023-03-17 |
| 2021-09-30 | $24.91M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $17.88M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $11.60M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $14.63M 10-K · filed 2022-02-25 |
| 2020-09-30 | $13.58M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $10.39M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $8.30M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $9.39M 10-K · filed 2021-03-16 |
| 2019-09-30 | $6.76M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $4.78M 10-Q · filed 2019-08-12 |
| 2018-12-31 | $2.34M 10-K · filed 2020-03-16 |